Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
EXAS Exact Sciences Corporation daily Stock Chart
EXAS [NASD]
Exact Sciences Corporation
Healthcare | Medical Laboratories & Research | USA
financial highlights | statements
Index- P/E- EPS (ttm)-1.76 Insider Own1.00% Shs Outstand131.22M Perf Week-3.83%
Market Cap12.33B Forward P/E- EPS next Y-1.18 Insider Trans-34.40% Shs Float126.55M Perf Month-1.19%
Income-218.80M PEG- EPS next Q-0.56 Inst Own86.80% Short Float6.27% Perf Quarter2.13%
Sales526.20M P/S23.44 EPS this Y30.70% Inst Trans-0.64% Short Ratio4.34 Perf Half Y39.71%
Book/sh6.15 P/B15.28 EPS next Y46.80% ROA-13.90% Target Price114.00 Perf Year77.39%
Cash/sh9.78 P/C9.62 EPS next 5Y20.00% ROE-30.00% 52W Range47.78 - 105.28 Perf YTD48.97%
Dividend- P/FCF- EPS past 5Y-15.80% ROI-11.60% 52W High-10.71% Beta1.84
Dividend %- Quick Ratio8.10 Sales past 5Y155.90% Gross Margin73.70% 52W Low96.73% ATR4.10
Employees1977 Current Ratio8.40 Sales Q/Q79.40% Oper. Margin-36.30% RSI (14)46.56 Volatility3.12% 4.02%
OptionableYes Debt/Eq1.02 EPS Q/Q-101.90% Profit Margin-41.60% Rel Volume0.87 Prev Close94.00
ShortableYes LT Debt/Eq1.02 EarningsApr 30 AMC Payout- Avg Volume1.83M Price94.00
Recom1.60 SMA20-3.81% SMA50-0.17% SMA20019.62% Volume0 Change0.00%
Feb-26-19Upgrade Goldman Neutral → Buy $85 → $120
Oct-09-18Initiated UBS Buy
Sep-05-18Resumed The Benchmark Company Hold
Aug-13-18Reiterated Canaccord Genuity Buy $62 → $65
Apr-03-18Upgrade BTIG Research Neutral → Buy
Jan-29-18Initiated Goldman Neutral $51
Jan-08-18Reiterated The Benchmark Company Buy $60 → $65
Nov-13-17Downgrade Robert W. Baird Outperform → Neutral $56
Nov-01-17Downgrade BTIG Research Buy → Neutral
Oct-31-17Reiterated The Benchmark Company Buy $50 → $60
Oct-03-17Reiterated Canaccord Genuity Buy $45 → $60
Sep-21-17Reiterated Leerink Partners Outperform $45 → $50
Jul-26-17Reiterated Lake Street Hold $30 → $41
Jul-26-17Reiterated Canaccord Genuity Buy $42 → $45
May-31-17Reiterated The Benchmark Company Buy $34 → $50
May-31-17Reiterated Canaccord Genuity Buy $38 → $40
Apr-17-17Initiated Leerink Partners Outperform $30
Feb-22-17Upgrade ROTH Capital Neutral → Buy
Feb-21-17Upgrade The Benchmark Company Hold → Buy $17 → $27
Nov-01-16Reiterated Lake Street Hold $8 → $15
May-23-19 03:03PM  Exact Sciences Corporation (NASDAQ:EXAS): When Will It Breakeven? Simply Wall St.
May-20-19 08:56AM  Exact Sciences Advances Pipeline Capabilities with Mayo Clinic PR Newswire
May-17-19 05:30AM  Exact Sciences Presents New Data Reinforcing Performance of Cologuard® PR Newswire
May-16-19 04:59PM  Exact Sciences returning $61K in WEDC tax credits because jobs were created outside Wisconsin: AP American City Business Journals
May-15-19 08:15AM  3 Top Healthcare Stocks to Buy in May Motley Fool
May-11-19 12:01PM  Guardant Health Takes Aim at Exact Sciences Motley Fool
May-09-19 09:00AM  Why Exact Sciences Shrugged Off the Moody Market in April Motley Fool
May-02-19 05:04PM  The stock markets reaction to this one word from the Feds Powell shows investors should be careful MarketWatch
05:46AM  Edited Transcript of EXAS earnings conference call or presentation 30-Apr-19 9:00pm GMT Thomson Reuters StreetEvents
May-01-19 06:22AM  Exact Sciences Corp (EXAS) Q1 2019 Earnings Call Transcript Motley Fool
06:00AM  Exact Sciences to participate in May investor conferences PR Newswire
Apr-30-19 09:30PM  What You'll Want to Know About Exact Sciences' Q1 Earnings Motley Fool
06:00PM  Exact Sciences: 1Q Earnings Snapshot Associated Press
05:24PM  Exact Sciences reports 79% jump in Cologuard test volume, first-quarter revenue American City Business Journals
04:05PM  First-quarter revenue and Cologuard test volume increased 79 percent to $162 million and 334,000, respectively PR Newswire
03:00PM  EXACT Sciences Corp. to Host Earnings Call ACCESSWIRE
11:45AM  The 5 Hottest Earnings Charts This Week Zacks
Apr-24-19 07:32AM  Older workers helped fuel recent U.S. growth. Can it last? Reuters
07:00AM  Older workers helped fuel recent U.S. growth. Can it last? Reuters
Apr-23-19 10:32AM  Earnings Preview: Exact Sciences (EXAS) Q1 Earnings Expected to Decline Zacks
Apr-22-19 05:34PM  Exact Sciences Is Near an All-Time High: Here's Why It Could Go Even Higher Motley Fool
11:08AM  Exact Sciences (EXAS) to Post Q1 Earnings: What's in Store? Zacks
07:23AM  7 Strong Buy Stocks the Street Loves InvestorPlace
Apr-16-19 02:34PM  Did Hedge Funds Drop The Ball On EXACT Sciences Corporation (EXAS) ? Insider Monkey
Apr-12-19 11:26AM  Goldman Adds EXACT Sciences To Americas Conviction List Benzinga
08:55AM  Announcing: Exact Sciences (NASDAQ:EXAS) Stock Rocketed An Astounding 1173% In The Last Three Years Simply Wall St.
Apr-08-19 06:00AM  Exact Sciences schedules first-quarter 2019 earnings call PR Newswire
Apr-04-19 04:24PM  Exact Sciences CEO on turning company around, stock soared 140% over the past year Yahoo Finance Video
Apr-01-19 05:00AM  Stocks That Would Have Made You Rich Today GOBankingRates
Mar-27-19 03:30PM  Why Exact Sciences Stock Sank Today Motley Fool -9.23%
01:13PM  8 Genomic Testing Stocks That Can Ease the Sting of Theranos InvestorPlace
Mar-25-19 07:14AM  Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)? Zacks
Mar-21-19 08:19AM  Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus Zacks
Mar-20-19 03:25PM  NASH, Allergies and Beauty Stocks: Invest or Not? Zacks
Mar-19-19 10:27AM  Exact Sciences appoints former Kansas governor, HHS secretary Sebelius to its board of directors American City Business Journals
08:00AM  Kathleen Sebelius Appointed to Exact Sciences Board PR Newswire
Mar-17-19 11:33AM  Better Buy: Exact Sciences vs. Illumina Motley Fool
Mar-12-19 03:22PM  5 Active Mutual Funds Worth Their Expenses InvestorPlace
07:16AM  Why Guardant Health Is the Best Healthcare Stock You've Never Heard Of Motley Fool
Mar-10-19 08:12AM  The 10 Top Stocks of the 10-Year Bull Market Motley Fool
Mar-08-19 01:35PM  Exact Sciences Looks Vulnerable: Protect Longs TheStreet.com
Mar-06-19 12:14AM  Exact Sciences Announces Upsizing and Pricing of 0.3750% Convertible Senior Notes Due 2027 PR Newswire
Mar-05-19 04:01PM  Exact Sciences Announces Offering of $600 Million Convertible Senior Notes Due 2027 PR Newswire
Mar-04-19 07:00AM  Market Trends Toward New Normal in Eaton Corporation, Kite Realty Group Trust, Intercontinental Exchange, SS&C Technologies, Exact Sciences, and Oshkosh Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Mar-01-19 06:00AM  Exact Sciences to participate in March investor conferences PR Newswire
Feb-28-19 08:24AM  The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems Benzinga -5.70%
Feb-27-19 06:00AM  Cologuard Helps Screen Two Million People for Colorectal Cancer PR Newswire
Feb-26-19 12:14PM  Exact Sciences A 'Must-Own' Growth Stock, Goldman Sachs Says In Upgrade Benzinga
07:32AM  What Investors Should Know About Exact Sciences Corporations (NASDAQ:EXAS) Financial Strength Simply Wall St.
Feb-25-19 12:01PM  Edited Transcript of EXAS earnings conference call or presentation 21-Feb-19 10:00pm GMT Thomson Reuters StreetEvents
Feb-24-19 09:00AM  Exact Sciences Hit a Home Run in Q4. Here's Why Sales Could Soon Soar Even More. Motley Fool
Feb-22-19 12:49AM  EXACT Sciences Corporation (EXAS) Q4 2018 Earnings Conference Call Transcript Motley Fool +10.52%
Feb-21-19 06:45PM  Exact Sciences (EXAS) Reports Q4 Loss, Misses Revenue Estimates Zacks
05:56PM  Exact Sciences: 4Q Earnings Snapshot Associated Press
05:34PM  Exact Sciences completes 934,000 Cologuard tests in 2018; annual revenue up 71% American City Business Journals
04:05PM  Total 2018 revenue increased 71 percent to $454 million, and 934,000 people were screened with Cologuard PR Newswire
09:28AM  Options Traders Expect Huge Moves in Exact Sciences (EXAS) Stock Zacks
Feb-20-19 04:06PM  Cutera Appoints Katherine Zanotti and Joseph Whitters to its Board of Directors GlobeNewswire
Feb-19-19 06:18PM  This Week's Hottest Earnings Charts Zacks
Feb-17-19 09:18AM  Could Exact Sciences Be a Millionaire-Maker Stock? Motley Fool
Feb-14-19 10:31AM  Analysts Estimate Exact Sciences (EXAS) to Report a Decline in Earnings: What to Look Out for Zacks
Feb-13-19 07:24AM  Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)? Zacks
Feb-10-19 09:00AM  The $100 Billion Investing Opportunity That Could Revolutionize Cancer Treatment Motley Fool
Feb-04-19 09:47PM  Here's Why Exact Sciences Soared 42.8% in January Motley Fool
06:00AM  Exact Sciences schedules fourth-quarter, full-year 2018 earnings call PR Newswire
Jan-29-19 09:03AM  4 Things Exact Sciences Investors Should Know About 23andMe's New Cancer Test Motley Fool
Jan-28-19 07:30AM  Analysis: Positioning to Benefit within Rollins, Hospitality Properties Trust, Exact Sciences, Tenet Healthcare, Entergy, and Calithera Biosciences Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jan-25-19 08:15PM  Exact Sciences Corp (EXAS) President and CEO Kevin T Conroy Sold $24.7 million of Shares GuruFocus.com
Jan-23-19 09:31AM  Is a Beat in Store for AbbVie (ABBV) This Earnings Season? Zacks
Jan-17-19 10:00AM  Exact Sciences (EXAS) Is Up 16.34% in One Week: What You Should Know Zacks
Jan-16-19 02:17PM  ls Cisco heading higher? Is Exact Sciences a takeover tar... CNBC Videos
Jan-15-19 02:08PM  Microbots Products in Focus After Huge Gains by MBOT Stock InvestorPlace
07:23AM  3 Healthcare Stocks Still Raising Expectations Motley Fool
Jan-14-19 02:00PM  What Caused Exact Sciences Shares to Fall 19.1% in December Motley Fool
Jan-07-19 04:48PM  Exact Sciences Stock Soars as Upbeat Forecast Raises Hopes Barrons.com +14.79%
04:09PM  Why Exact Sciences Soared Today Motley Fool
11:07AM  Exact Sciences' stock rises as company anticipates $455M in 2018 revenue American City Business Journals
09:01AM  Exact Sciences Stock Soars, General Motors Gains and 5 More Monday Morning Movers Barrons.com
06:50AM  Today's Research Reports on Trending Tickers: Exact Sciences and Illumina ACCESSWIRE
Jan-06-19 07:00PM  Exact Sciences to report $454-455M in total revenue, 71-percent growth for 2018 PR Newswire
Dec-25-18 01:49PM  Does Exact Sciences Corporations (NASDAQ:EXAS) CEO Pay Matter? Simply Wall St.
Dec-21-18 08:47AM  Are Options Traders Betting on a Big Move in Exact Sciences (EXAS) Stock? Zacks
Dec-20-18 06:00AM  Exact Sciences to participate in J.P. Morgan Healthcare Conference PR Newswire -8.69%
Dec-19-18 12:19AM  4 Stocks Former Billionaire Barry Rosenstein Bought in Q3 (and 1 He Dumped) Insider Monkey -5.09%
Dec-17-18 07:14AM  Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)? Zacks
Dec-13-18 07:00AM  Today's Research Reports on Trending Tickers: Neogen and Exact Sciences ACCESSWIRE -5.49%
Nov-25-18 10:19AM  Is Exact Sciences Corporation (NASDAQ:EXAS) Going to Burn These Hedge Funds? Insider Monkey
Nov-23-18 11:17AM  These 3 Stocks Are Up 25% in 2018 -- Are They Still Buys? Motley Fool
Nov-16-18 04:59PM  Better Buy: EXACT Sciences Corporation vs. Illumina Motley Fool
Nov-14-18 07:15PM  Exact Sciences Corp (EXAS) President and CEO Kevin T Conroy Sold $11.3 million of Shares GuruFocus.com
Nov-13-18 06:51AM  Todays Research Reports on Stocks to Watch: OPKO Health and Exact Sciences ACCESSWIRE
Nov-09-18 06:00AM  Exact Sciences to participate in two November investor conferences PR Newswire
Nov-06-18 06:32AM  Is Exact Sciences Corporation a Buy? Motley Fool
Nov-05-18 07:25AM  Report: Exploring Fundamental Drivers Behind MRC Global, Exact Sciences, Owens-Illinois, Copart, Cognizant Technology Solutions, and Owens & Minor New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-02-18 04:50PM  Exact Sciences CEO on the Cologuard maker's surge in reve... CNBC Videos
12:40PM  Eaton Vance Worldwide Health Sciences Fund Picks Up 6 Stocks in 3rd Quarter GuruFocus.com
Nov-01-18 04:30PM  Edited Transcript of EXAS earnings conference call or presentation 30-Oct-18 9:00pm GMT Thomson Reuters StreetEvents
01:23PM  Exact Sciences Stock: Buy at What Level? TheStreet.com
08:46AM  Here's What Exact Sciences Just Said About Its Future Motley Fool
Oct-31-18 02:18PM  Why Accuray Is Soaring Today Motley Fool +10.33%
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stenhouse MarkPresident, CologuardApr 03Sale92.5411,1921,035,69614,308Apr 04 04:24 PM
Stenhouse MarkPresident, CologuardApr 02Option Exercise0.0025,000025,500Apr 04 04:24 PM
Conroy Kevin TPresident and CEOMar 11Sale87.2111,227979,129938,526Mar 12 05:16 PM
COWARD D SCOTTChief Administrative OfficerMar 11Sale87.212,774241,926103,096Mar 12 05:19 PM
COWARD D SCOTTChief Administrative OfficerMar 09Option Exercise0.006,0250105,870Mar 12 05:19 PM
Conroy Kevin TPresident and CEOMar 09Option Exercise0.0024,4000949,753Mar 12 05:16 PM
Zanotti Katherine SDirectorFeb 28Sale92.8125,0002,320,23177,102Mar 01 05:36 PM
WYZGA MICHAEL SDirectorFeb 28Sale96.0050048,0008,612Mar 01 05:34 PM
Johnson Scott C.SVP - Research and DevelopmentFeb 28Sale93.201,166108,6767,652Mar 01 05:32 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 28Sale93.202,447228,07040,644Mar 01 05:29 PM
Doyle James EdwardDirectorFeb 28Sale96.002,000192,00035,093Mar 01 05:25 PM
COWARD D SCOTTChief Administrative OfficerFeb 28Sale93.202,447228,07099,845Mar 01 05:24 PM
Conroy Kevin TPresident and CEOFeb 28Sale93.2010,014933,345925,353Mar 01 05:21 PM
Carey Thomas D.DirectorFeb 28Sale96.007,500720,00041,483Mar 01 05:19 PM
Conroy Kevin TPresident and CEOFeb 27Option Exercise0.0020,5750935,367Feb 28 08:10 PM
COWARD D SCOTTChief Administrative OfficerFeb 27Option Exercise0.005,0250102,292Feb 28 08:15 PM
Johnson Scott C.SVP - Research and DevelopmentFeb 27Option Exercise0.003,52508,818Feb 28 08:20 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27Option Exercise0.005,025043,091Feb 28 08:18 PM
Conroy Kevin TPresident and CEOFeb 27Sale95.079,169871,734914,792Feb 28 08:10 PM
COWARD D SCOTTChief Administrative OfficerFeb 27Sale95.079,803932,01097,267Feb 28 08:15 PM
COWARD D SCOTTChief Administrative OfficerFeb 26Option Exercise0.0021,4000107,070Feb 28 08:15 PM
Conroy Kevin TPresident and CEOFeb 26Option Exercise0.0020,0250923,961Feb 28 08:10 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 25Sale90.554,445402,49938,066Feb 26 05:34 PM
Conroy Kevin TPresident and CEOFeb 25Sale90.5516,4001,485,036903,936Feb 26 05:29 PM
COWARD D SCOTTChief Administrative OfficerFeb 25Sale90.556,143556,25585,670Feb 26 05:32 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Option Exercise0.0012,850091,813Feb 26 05:32 PM
Conroy Kevin TPresident and CEOFeb 23Option Exercise0.0034,3250920,336Feb 26 05:29 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Option Exercise0.009,300042,511Feb 26 05:34 PM
Conroy Kevin TPresident and CEOJan 25Sale81.27304,39724,737,400886,011Jan 25 06:46 PM
Conroy Kevin TPresident and CEOJan 24Option Exercise0.00304,39701,190,408Jan 25 06:46 PM
Elliott Jeffrey ThomasChief Financial OfficerJan 24Sale78.9090,9097,172,54833,211Jan 25 06:48 PM
COWARD D SCOTTChief Administrative OfficerJan 24Sale78.21169,10913,226,22678,963Jan 25 06:47 PM
COWARD D SCOTTChief Administrative OfficerJan 23Option Exercise0.00169,1090248,072Jan 25 06:47 PM
Elliott Jeffrey ThomasChief Financial OfficerJan 23Option Exercise0.0090,9090124,120Jan 25 06:48 PM
COWARD D SCOTTChief Administrative OfficerJan 03Sale62.751,58199,21478,963Jan 04 04:56 PM
COWARD D SCOTTChief Administrative OfficerJan 02Option Exercise0.004,687080,544Jan 04 04:56 PM
Conroy Kevin TPresident and CEONov 12Option Exercise0.83163,514135,7171,049,525Nov 14 05:09 PM
Zanotti Katherine SDirectorNov 12Option Exercise3.437,66726,298109,769Nov 14 05:11 PM
Conroy Kevin TPresident and CEONov 12Sale69.00163,51411,282,466886,011Nov 14 05:09 PM
Zanotti Katherine SDirectorNov 12Sale69.007,667529,023102,102Nov 14 05:11 PM
LIDGARD GRAHAM PETERChief Science OfficerNov 07Sale75.0169852,35728,700Nov 07 05:33 PM
LIDGARD GRAHAM PETERChief Science OfficerNov 05Sale75.0137,6132,821,27629,398Nov 07 05:33 PM
LIDGARD GRAHAM PETERChief Science OfficerNov 01Sale70.3357,5174,045,34267,011Nov 02 05:40 PM
LIDGARD GRAHAM PETERChief Science OfficerOct 31Sale75.3522,1561,669,499124,528Nov 02 05:40 PM
LIDGARD GRAHAM PETERChief Science OfficerOct 08Sale69.3658,0004,022,933146,684Oct 10 04:10 PM
COWARD D SCOTTChief Administrative OfficerOct 01Sale79.512,190174,11875,857Oct 02 04:28 PM
COWARD D SCOTTChief Administrative OfficerSep 30Option Exercise0.004,688078,047Oct 02 04:28 PM
WYZGA MICHAEL SDirectorAug 28Sale74.852,468184,7309,112Aug 30 05:26 PM
Zanotti Katherine SDirectorJul 30Sale58.862,847167,574106,197Aug 01 05:09 PM
Doyle James EdwardDirectorJul 30Sale58.861,31877,57737,093Aug 01 05:06 PM
Fallon John A.DirectorJul 30Sale58.862,373139,67533,767Aug 01 05:07 PM
Carey Thomas D.DirectorJul 30Sale58.863,427201,71348,983Aug 01 05:04 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 30Sale57.788,984519,09632,456Jul 31 08:34 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 28Option Exercise0.0018,750041,440Jul 31 08:34 PM
COWARD D SCOTTSVP and General CounselJul 02Sale59.102,135126,17673,359Jul 03 04:10 PM
COWARD D SCOTTSVP and General CounselJun 30Option Exercise0.004,687075,494Jul 03 04:10 PM
open in yahoo | open in reuters | open in google